The Enterprise Value as of December 2025 (TTM) for Glenmark Pharmaceuticals Limited (GLENMARK.NS) is 555.43B

According to Glenmark Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 555.43B. This represents a change of 18.95% compared to the average of 466.93B of the last 4 quarters.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Historical Enterprise Value (quarterly & annually)

How has GLENMARK.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Glenmark Pharmaceuticals Limited over the last ten years is 223.08B. The current 555.43B Enterprise Value has changed 24.80% with respect to the historical average. Over the past ten years (40 quarters), GLENMARK.NS's Enterprise Value was at its highest in in the June 2025 quarter at 495.19B. The Enterprise Value was at its lowest in in the March 2020 quarter at 98.83B.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Glenmark Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Average Enterprise Value

How has GLENMARK.NS Enterprise Value performed in the past?

The current Enterprise Value of Glenmark Pharmaceuticals Limited (GLENMARK.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Glenmark Pharmaceuticals Limited (GLENMARK.NS) Enterprise Value vs. Peers

How is GLENMARK.NS’s Enterprise Value compared to its peers?

Glenmark Pharmaceuticals Limited’s Enterprise Value is less than Laurus Labs Limited (575.43B), less than Laurus Labs Limited (575.43B), less than Aurobindo Pharma Limited (696.22B), less than Alkem Laboratories Limited (699.89B), less than Aurobindo Pharma Limited (696.22B), less than Alkem Laboratories Limited (699.89B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B), greater than GlaxoSmithKline Pharmaceuticals Limited (424.12B), less than Biocon Limited (646.83B), less than Biocon Limited (646.83B),

Build a custom stock screener for Glenmark Pharmaceuticals Limited (GLENMARK.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Glenmark Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Glenmark Pharmaceuticals Limited (GLENMARK.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Glenmark Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.